G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/03/2004	EP1472363A2 Method and test strips for the measurement of fat loss during weight loss programs
11/03/2004	EP1472362A1 Fabrication method of multisensors chips for detecting analytes
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472349A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities
11/03/2004	EP1472344A2 Novel protein
11/03/2004	EP1472339A1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis
11/03/2004	EP1472335A2 Methods and systems of nucleic acid sequencing
11/03/2004	EP1472287A1 Rhamnose binding protein
11/03/2004	EP1472281A1 Gene conferring resistance to phytophthera infestans (late-blight) in solanaceae
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472266A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents
11/03/2004	EP1472252A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/03/2004	EP1471931A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/03/2004	EP1471929A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471906A1 Stimulation of cpt-1 as a means to reduce weight
11/03/2004	EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/03/2004	EP1456176A4 Improved compounds for generating chemiluminescence with a peroxidase
11/03/2004	EP1392150A4 Improvements to diagnosis of acute myocardial infarction and other clinical conditions
11/03/2004	EP1358344A4 Dendritic chemiluminescent substrates
11/03/2004	EP1311706A4 A method of detecting microorganisms
11/03/2004	EP1307722B1 Exhaust gas particulate mass measurement apparatus with real-time moisture monitor
11/03/2004	EP1278547B1 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/03/2004	EP1268508A4 Quality control reagents for nucleic acid microarrays
11/03/2004	EP1206494B1 Computational design methods for making molecular mimetics
11/03/2004	EP1204746B1 Sentrin-specific human protease senp1
11/03/2004	EP1181348B1 Apparatus and method of testing a biological fluid
11/03/2004	EP1113839B1 Variable output applicator for multi-component biologic fluid agents
11/03/2004	EP1110092B1 Detection and determination of the stages of coronary artery disease
11/03/2004	EP1100965A4 Method of and composite for fluorescent in situ hybridization
11/03/2004	EP1068155A4 Substrate for array printing
11/03/2004	EP1009807A4 DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ER$g(a) AND ER$g(b) AT AP1 SITES
11/03/2004	EP1003904A4 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
11/03/2004	EP0929669B1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis
11/03/2004	EP0927249B1 E2f ubiquitination domain, and assays for inhibitors of e2f ubiquitination
11/03/2004	EP0827425B1 Combination reagent holding and test device
11/03/2004	EP0821794B1 Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays
11/03/2004	EP0705338B1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)
11/03/2004	EP0698216B1 Methods of typing hepatitis c virus and reagents for use therein
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	EP0594843B1 Antibody assay for amylin
11/03/2004	CN2653511Y Kelunteluo fast semi quantitative detection test paper
11/03/2004	CN2653510Y Anti-nuclear antigen detection cell thin sheet
11/03/2004	CN2653509Y Disposable underwater section measurer
11/03/2004	CN2653492Y Detector for CO2 binding force
11/03/2004	CN1543572A Imaging means for excisions apparatus
11/03/2004	CN1543571A Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment
11/03/2004	CN1543570A Identifying compounds that modulate interaction of neuronal nitric oxide synthase and its inhibitor, useful e.g. for treating prediabetic states
11/03/2004	CN1543569A Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
11/03/2004	CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004	CN1543476A Methods and compounds for the targeting of protein to exosomes
11/03/2004	CN1543474A T1R taste receptors and genes encoding same
11/03/2004	CN1542454A Chemical analyzer and structure for chemical analysis
11/03/2004	CN1542453A Hemoglobin determination apparatus
11/03/2004	CN1542452A Preparation method of CdSe nano-crystalline composite liposome microcapsule bubble used for fluorescence immunity detection
11/03/2004	CN1542451A Preparation method of CdSe nanometer crystal composite liposome microcapsule bubble used for fluorescence immunity detection
11/03/2004	CN1542450A Preparation method of CdSe nano-crystalline composite liposome microcapsule bubble used for fluorescence immunity detection
11/03/2004	CN1542449A Nuclear/shell type superparamagnetism composite particulate, preparation method and application thereof
11/03/2004	CN1542437A Microwave measuring arrangement for product density measurement
11/03/2004	CN1542143A Colorectal cancer prognostics
11/03/2004	CN1541715A [188Re(H2O)3(CO)3]+ reagent kit and preparation
11/03/2004	CN1174249C Method for counting leukocytes and leukocyte counter
11/03/2004	CN1174248C Graphitic nanotube for electrochemiluminescent detection , its composition ,detection agent and detection method thereof
11/03/2004	CN1174240C Method and apparatus for measuring lipid peroxidation in biological fluids and suspensions of tissues
11/03/2004	CN1174239C Spectiogram biological chip detector
11/03/2004	CN1174099C Nucleic acid vaccines encoding G protein of respiratory syncytial virus
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173954C Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
11/03/2004	CN1173871C Method for detecting break point of thread and apparatus therefor
11/03/2004	CN1173776C High-throughput screening assay systems in microscale fluidic devices
11/03/2004	CN1173624C Method and apparatus for classifying poultry eggs
11/02/2004	US6813007 Apparatus for generating data for determining a property of a gemstone and methods and computer programs for determining a property of a gemstone
11/02/2004	US6812834 Fire detector testing; reproducibly generating combustion products of aircraft cargo hold; simulating both smoldering and flaming conditions
11/02/2004	US6812457 Interfaces with mass spectrometer; efficient sample concen-tration, purification and/or transformation; reproducibility; minimizing analyte loss; parallel treatment; disposable
11/02/2004	US6812456 Microfluidic system (EDI)
11/02/2004	US6812335 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812239 Method of identification of inhibitors of PDE1C and methods of treatment of diabetes
11/02/2004	US6812224 Phosphorous organic compounds and their use
11/02/2004	US6812213 Steroidal sapogenins and their derivatives for treating alzheimer's disease
11/02/2004	US6812212 Evaluating oxidative stress; obtain sample, incubate with chemical intermediates, measure polymerization of proteins
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812038 Assay device and use thereof
11/02/2004	US6812036 Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains
11/02/2004	US6812033 Measuring the levels of lipids, low density lipoproteins and high density lipoproteins particles, determining therapy for treatment
11/02/2004	US6812031 Regeneration of biosensors
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812023 Methods of producing membrane vesicles
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
11/02/2004	US6811999 Method for determining calciotropic activity of a preparation of Padina pavonica algae
11/02/2004	US6811998 Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
11/02/2004	US6811997 Method for chromium analysis and speciation
11/02/2004	US6811995 Non-invasive enzyme screen for cancer
11/02/2004	US6811993 Diagnostic and screening methods based on monocyte PKC activity
11/02/2004	US6811992 Mixed-lineage kinases (mlks); for preventing neurodegenerative diseases characterized by glutamine or kainate mediated toxicity (huntington's/alzheimer's disease); drug screening
11/02/2004	US6811988 Compositions and methods for diagnosing Alzheimer's disease

1 ... 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 ... 3937